Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells.

Abstract

After exposure to low density lipoprotein (LDL) that had been minimally modified by oxidation (MM-LDL), human endothelial cells (EC) and smooth muscle cells (SMC) cultured separately or together produced 2-to 3-fold more monocyte chemotactic activity than did control cells or cells exposed to freshly isolated LDL. This increase in monocyte chemotactic activity was paralleled by increases in mRNA levels for a monocyte chemotactic protein 1 (MCP-1) that is constitutively produced by the human glioma U-105MG cell line. Antibody that had been prepared against cultured baboon smooth muscle cell chemotactic factor (anti-SMCF) did not inhibit monocyte migration induced by the potent bacterial chemotactic factor f-Met-Leu-Phe. However, anti-SMCF completely inhibited the monocyte chemotactic activity found in the media of U-1O5MG cells, EC, and SMC before and after exposure to MM-LDL. Moreover, monocyte migration into the subendothelial space of a coculture of EC and SMC that had been exposed to MM-LDL was completely inhibited by anti-SMCF. Anti-SMCF specifically immunoprecipitated 10-kDa and 12.5-kDa proteins from EC. Incorporation of [35Slmethi-onine into the immunoprecipitated proteins paralleled the monocyte chemotactic activity found in the medium of MM-LDL stimulated EC and the levels of MCP-1 mRNA found in the EC. We conclude that (g) SMCF is in fact MCP-1 and (it) MCP-1 is induced by MM-LDL.An important early event in atherogenesis is an increased recruitment of monocytes into the arterial subendothelium (1)(2)(3)(4). Previous studies have shown that endothelial cells (EC) (5, 6) and smooth muscle cells (SMC) (7,8) in culture constitutively produce a chemotactic factor that acts on monocytes but not neutrophils. Graves and colleagues (9) demonstrated that the monocyte chemotactic activity in the supernatants from a number of tumor cell lines was inhibited by an antibody made against baboon smooth muscle cell chemotactic factor (anti-SMCF) (10). Additionally they demonstrated a strong concordance with immunoprecipitation of a protein with an apparent molecular mass of 14.4 kDa. A human glioma cell line, U-1OSMG, constitutively expresses monocyte chemotactic activity. The protein responsible for this activity has been purified, sequenced, and named monocyte chemotactic protein 1 (MCP-1) (11, 12). Graves and colleagues did not test their antibody against the chemotactic activity secreted by the U-1O5MG cell line, but based on limited primary sequence data from the baboon smooth muscle chemotactic protein, they concluded that their protein was homologous to MCP-1.We have recently demonstrated that low density lipoprotein (LDL) that has been minimally modified (MM-LDL) is indistinguishable from native LDL by the LDL receptor, is not recognized by the scavenger receptor, and induces EC to secrete high levels of monocyte chemotactic activity, whereas native LDL does not (13). We have also shown that MM-LDL induces EC to produce colony-stimulating factors, including monocyte colony-stimulating factor (M-CSF), w...

FSP1+ Fibroblasts Promote Skin Carcinogenesis by Maintaining MCP-1-Mediated Macrophage Infiltration and Chronic Inflammation

“…These results suggest that MCP-1 promotes skin tumor development mainly by recruitment of macrophages and elevation of inflammation, which is consistent with reduced papilloma development in MCP-1 Ϫ/Ϫ mice. 39 It should be noted that MCP-1 can be secreted by different cell types, such as fibroblasts, 50 macrophages, 51,52 endothelial cells, 53 and epithelial cells. 54 In our experiments, the decreased level of MCP-1 in the skin on depletion of FSP1 ϩ cells and the enhanced ability to produce MCP-1 after TPA stimulation by fibroblasts indicate that MCP-1 secreted by fibroblasts is sufficient to maintain DMBA/TPA-induced skin inflammation.…”

Cytotoxic and chemotactic potencies of several aldehydic components of oxidised low density lipoprotein for human monocyte‐macrophages

“…This monocytespecific adhesion molecule has not been fully characterized so far, but it is different from E-selectin, VCAM-1 and ICAM-1. Furthermore, minimally-modified LDL stimulates endothelial cells and smooth muscle cells to express a monocyte-specific chemoattractant, MCP-1 [33]. Oxidised LDL stimulates the expression of P-selectin by rat endothelial cells [34], facilitating leukocyte-endothelium interactions, and lysophosphatidyl choline, which was reported to selectively attract monocytes [4], stimulates the expression of leukocyte-adhesion molecules ICAM-1 and VCAM-1 on rat and human endothelial cells [35].…”

Circulating MCP-1 levels shows linkage to chemokine receptor gene cluster on chromosome 3: the NHLBI Family Heart Study follow-up examination

“…MCP-1 expression was upregulated in human atheromatous plaques compared to normal tissue 3 and in endothelial and smooth muscle cells exposed to modified low-density lipoprotein (LDL). 4 In human studies, serum levels of MCP-1 have been associated with older age, female sex, hypertension, diabetes, history of coronary disease, renal insufficiency, measures of adiposity and other inflammatory mediators including C-reactive protein (CRP), interleukin-6, interleukin-18, interleukin-8 and IP-10. [5][6][7] However, the relationship between levels of MCP-1 and risk of atherosclerotic diseases is inconsistent.…”